Stockscreener 앱 받기
1.42
2.07%
-0.03
시간 외 거래:
1.41
-0.01
-0.70%
전일 마감가:
$1.45
열려 있는:
$1.47
하루 거래량:
228.00K
Relative Volume:
0.14
시가총액:
$48.82M
수익:
-
순이익/손실:
$-16.14M
주가수익비율:
-2.6296
EPS:
-0.54
순현금흐름:
$-3.99M
1주 성능:
+0.71%
1개월 성능:
+5.19%
6개월 성능:
-27.55%
1년 성능:
-72.69%
1일 변동 폭
$1.405
$1.48
1주일 범위
$1.3702
$1.49
52주 변동 폭
$1.12
$5.40
Telomir Pharmaceuticals Inc Stock (TELO) Company Profile
명칭
Telomir Pharmaceuticals Inc
전화
786-396-6723
주소
100 SE 2ND ST, MIAMI
TELO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TELO
Telomir Pharmaceuticals Inc
|
1.42 | 49.85M | 0 | -16.14M | -3.99M | -0.54 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.71 | 114.69B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
752.62 | 77.91B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
850.95 | 54.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
391.50 | 52.52B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
196.92 | 42.02B | 447.02M | -1.18B | -906.14M | -6.1812 |
Telomir Pharmaceuticals Inc Stock (TELO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-02-21 | 개시 | Rodman & Renshaw | Buy |
Telomir Pharmaceuticals Inc 주식(TELO)의 최신 뉴스
Telomir Pharmaceuticals Reports New Data Showing Telomir-1 Significantly Reduces PSA Levels in Human Prostate Cancer Cells - USA Today
Telomir Pharmaceuticals Reports Discovery That Telomir-1 Selectively Kills Aggressive Triple-Negative Breast Cancer Cells - Daily Commercial
Telomir Pharmaceuticals Inc. (TELO) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Why Telomir Pharmaceuticals Inc. stock attracts high net worth investorsTrade Signal Summary & Free Community Supported Trade Ideas - Newser
Telomir Pharmaceuticals (NASDAQ:TELO) Shares Up 2.3% – Still a Buy? - Defense World
Is Telomir Pharmaceuticals Inc. stock positioned for digital transformationJuly 2025 Chart Watch & Real-Time Volume Triggers - moha.gov.vn
Telomir Pharmaceuticals announces new preclinical data on Telomir-1 - MSN
Telomir and Mira Pharmaceuticals advance through key development milestones with Recipharm support - marketscreener.com
Telomir Pharmaceuticals Unveils Promising Preclinical Cancer Data - MSN
Telomir reports PSA reduction in prostate cancer cells with lead drug - Investing.com Nigeria
Telomir reports PSA reduction in prostate cancer cells with lead drug By Investing.com - Investing.com South Africa
Telomir Pharmaceuticals Reports Promising Preclinical Data - TipRanks
[8-K] Telomir Pharmaceuticals, Inc. Reports Material Event | TELO SEC FilingForm 8-K - Stock Titan
Telomir Pharmaceuticals Announces Telomir-1 Kills Aggressive Human Leukemia Cells - Bluffton Today
TELO Stock Jumps Pre-market After Early Study Results Show Leukemia Cell Death - MSN
Will Telomir Pharmaceuticals Bounce Back? - StocksToTrade
Telomir Pharmaceuticals (TELO) Unveils Leukemia Breakthrough and Board Change – Full Investor Update for November 21, 2025 - ts2.tech
Telomir stock surges after leukemia cell-killing data By Investing.com - Investing.com Nigeria
Telomir stock surges after leukemia cell-killing data - Investing.com UK
Telomir Pharma (NASDAQ: TELO) Telomir-1 Shows Preclinical HL60 Leukemia Activity - Stock Titan
Telomir Pharmaceuticals director Craig Eagle resigns from board By Investing.com - Investing.com Australia
Telomir Pharmaceuticals director Craig Eagle resigns from board - Investing.com
Telomir Pharmaceuticals Inc. Announces Resignation of Craig Eagle as Director, Effective on November 14, 2025 - MarketScreener
Telomir Pharmaceuticals’ Telomir-1 Shows Leukemia Efficacy - TipRanks
Telomir Pharmaceuticals, Inc. Announces Telomir-1 Kills Aggressive Human Leukemia Cells - marketscreener.com
How Telomir Pharmaceuticals Inc. stock performs after earnings2025 Market Overview & Precise Buy Zone Tips - newser.com
Does Telomir Pharmaceuticals Inc. stock trade at a discount to peersQuarterly Portfolio Summary & Daily Stock Trend Watchlist - newser.com
Will Telomir Pharmaceuticals Inc. bounce back from current supportMarket Activity Recap & Precise Buy Zone Tips - newser.com
Has Telomir Pharmaceuticals Inc. found a price floorJuly 2025 PreEarnings & Weekly Breakout Opportunity Watchlist - newser.com
Telomir Pharmaceuticals Completes $2.9 Million Stock Sale - MSN
Analyzing Telomir Pharmaceuticals Inc. with risk reward ratio charts2025 AllTime Highs & Daily Volume Surge Trade Alerts - newser.com
Telomir Pharmaceuticals Inc (TELO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.36%
1.12%
자본화:
|
볼륨(24시간):